Ashley Santillo
Adult Health · Fairport, NYNPI 1912396177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 325 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,798 and has fallen 97.0% since, to $55 in 2025. Among adult health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$872
- Novo Nordisk$467
- Lilly USA, LLC$453
- Amgen$417
- Pfizer$246
- Baxter Healthcare$208
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,60895%
- Education$251%
- Other$2084%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $872 |
| Novo Nordisk | 47 | $467 |
| Lilly USA, LLC | 32 | $453 |
| Amgen | 25 | $417 |
| Pfizer | 25 | $246 |
| Baxter Healthcare | 1 | $208 |
| GSK | 12 | $202 |
| Novartis | 10 | $199 |
| AstraZeneca | 10 | $164 |
| Bayer | 9 | $155 |
| Boehringer Ingelheim | 9 | $155 |
| E.r. Squibb & Sons, L.L.C. | 10 | $155 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $145 |
| Currax Pharmaceuticals LLC | 7 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $93 |
| Amarin Pharma, Inc. | 4 | $91 |
| Biohaven Pharmaceuticals, Inc. | 3 | $88 |
| Merck | 5 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Johnson & Johnson | 4 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Ironwood Pharmaceuticals, Inc | 3 | $60 |
| Insulet Corporation | 3 | $55 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Biogen | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Exact Sciences | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
How this compares
$4,841 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 21 | $20,817 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $1,458 |
| Atorvastatin Calcium | 76 | $1,289 |
| Omeprazole | 43 | $1,127 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $1,044 |
| Levothyroxine Sodium | 47 | $801 |
| Duloxetine Hcl | 18 | $681 |
| Rosuvastatin Calcium | 24 | $632 |
| Famotidine | 16 | $456 |
| Fenofibrate | 12 | $453 |
| Pantoprazole Sodium | 16 | $442 |
| Amlodipine Besylate | 58 | $429 |
| Metoprolol Succinate | 18 | $384 |
| Losartan Potassium | 19 | $363 |
| Gabapentin | 22 | $344 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $467 | $20,81721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,828 adult health providers in New York.
Other adult health in Fairport
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Mary CiechoskiBuffalo$200K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
- Danielle BrunoPlainview$61K
- Julie PlantamuraPort Jefferson Station$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.